Additionally, patients with severe COVID-19 and acute respiratory distress syndrome (ARDS) admitted to intensive care units (ICUs) exhibited reduced serum GPx3 activity, which was significantly improved after 10–14 days of selenium supplementation [24]. This evidence concerns the gene GPX3 and COVID-19.